Share issuance through the exercise of stock acquisition rights and increases in share capital and capital reserves
First written in FY2023-Q3. 11 of 12 entries say "Advanced", first in FY2023. Latest entry: FY2027-H1.
102 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「1 March 2026–31 August 2026 (Note) 20,400 32,169,108 4,580 609,880 4,580 894,434」
During the interim consolidated accounting period, the number of shares increased by 20,400 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥4.580 million. - FY2026AdvancedAnnual report
「Between 1 March 2025 and 28 February 2026, the total number of issued shares increased by 74,800 through the exercise of stock acquisition rights.」
During the consolidated fiscal year, the number of shares increased by 74,800 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥1.603 million. - FY2026-H1AdvancedAnnual report
「1 March 2025–31 May 2025 5,200 16,039,554 137 603,834 137 888,389 1 June 2025–31 August 2025 12,800 32,091,908 348 604,182 348 888,737」
During the interim consolidated accounting period, the number of shares increased by 18,000 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥485,000. - FY2025AdvancedAnnual report
「Between 1 March 2024 and 28 February 2025, the number of shares increased by 39,600 through the exercise of stock acquisition rights and by 102,154 through the issuance of new shares in connection with a share exchange.」
The number of shares increased by 39,600 through the exercise of stock acquisition rights, and the increase in stated capital and capital surplus is reported. - FY2025-H1AdvancedAnnual report
「1 March 2024–31 August 2024」
During the interim consolidated accounting period, the number of shares increased by 19,400 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥689,000. - FY2025-Q1AdvancedAnnual report
「1 March 2024–31 May 2024 6,400 15,899,000 344 601,766 344 551,766」
During the first quarter, 6,400 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital reserve by ¥344,000. - FY2024AdvancedAnnual report
「The number of common shares increased by 51,600 through the exercise of stock acquisition rights.」
During the consolidated fiscal year, the number of shares increased by 51,600 through the exercise of stock acquisition rights, while stated capital and the capital reserve each increased by ¥2.059 million. - FY2024-Q3AdvancedAnnual report
「1 September 2023–31 October 2023 10,200 7,937,200 1,236 600,939 1,236 550,939 1 November 2023–30 November 2023 5,200 15,879,600 137 601,076 137 551,076」
Through the exercise of stock acquisition rights, 10,200 shares were issued from September to October 2023 and 5,200 shares in November, increasing both stated capital and the capital reserve. - FY2024-Q2AdvancedAnnual report
「1 June 2023–31 August 2023 2,600 7,927,000 136 599,702 136 549,702」
During the second quarterly consolidated accounting period, 2,600 shares were issued through the exercise of stock acquisition rights, increasing capital and capital surplus by ¥136 thousand each. - FY2024-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between 1 March and 31 May 2023, 3,900 shares were issued through the exercise of stock acquisition rights, increasing capital and capital surplus by ¥204 thousand each. - FY2023AdvancedAnnual report
「1 March 2022–28 February 2023 130,500 7,920,500 6,561 599,361 6,561 549,361」
During the current consolidated fiscal year, 130,500 shares were issued through the exercise of stock acquisition rights, increasing capital and capital surplus by ¥6.561 million each. - FY2023-Q3First statedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The fact that 16,900 shares were issued through the exercise of stock acquisition rights between 1 September and 30 November 2022, increasing capital and capital surplus by ¥887 thousand each, is disclosed.